154 related articles for article (PubMed ID: 1172958)
1. Editorial: Let's stop the Donnybrook. A perspective on the UGDP-Biometric Society Study.
Moser RH
JAMA; 1975 Mar; 231(12):1274-6. PubMed ID: 1172958
[No Abstract] [Full Text] [Related]
2. Management of adult-onset diabetes. The impact of the University Group Diabetes Program.
Goetz FC
Postgrad Med; 1972 Jul; 52(1):63-8. PubMed ID: 5067890
[No Abstract] [Full Text] [Related]
3. The FDA and hypoglycemic drugs.
Davidson JK
JAMA; 1975 May; 232(8):853-5. PubMed ID: 1091764
[No Abstract] [Full Text] [Related]
4. "Settling the UGDP controversy"?
Bradley RF; Dolger H; Forsham PH; Seltzer H
JAMA; 1975 May; 232(8):813-7. PubMed ID: 1091759
[No Abstract] [Full Text] [Related]
5. Editorial: Settling the UGDP controversy.
Chalmers TC
JAMA; 1975 Feb; 231(6):624-5. PubMed ID: 1172848
[No Abstract] [Full Text] [Related]
6. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents.
JAMA; 1975 Feb; 231(6):583-608. PubMed ID: 1089822
[No Abstract] [Full Text] [Related]
7. The oral hypoglycemic controversy. Stay as sweet as you are.
Gregory DR
Leg Aspects Med Pract; 1979 Mar; 7(3):16-9. PubMed ID: 106193
[No Abstract] [Full Text] [Related]
8. Oral hypoglycaemics in diabetes mellitus.
Lancet; 1975 Sep; 2(7933):489-91. PubMed ID: 51292
[No Abstract] [Full Text] [Related]
9. [Heart death and oral antidiabetics; the last judgement].
Touber JL
Ned Tijdschr Geneeskd; 1975 Sep; 119(39):1506-8. PubMed ID: 1101083
[No Abstract] [Full Text] [Related]
10. Clinical pharmacology of oral antidiabetic agents (second of two parts).
Shen SW; Bressler R
N Engl J Med; 1977 Apr; 296(14):787-93. PubMed ID: 320484
[No Abstract] [Full Text] [Related]
11. Antidiabetic agents and vascular events.
Keen H
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():99-105. PubMed ID: 783218
[No Abstract] [Full Text] [Related]
12. Controversy over study of diabetes drugs continues for nearly a decade.
Kolata GB
Science; 1979 Mar; 203(4384):986-90. PubMed ID: 370980
[No Abstract] [Full Text] [Related]
13. The oral antidiabetic agents.
Bierman EL
Am Fam Physician; 1976 Jan; 13(1):98-104. PubMed ID: 1251792
[TBL] [Abstract][Full Text] [Related]
14. Audit confirms conclusions of UGDP study on oral diabetes drugs.
FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34-6. PubMed ID: 720789
[No Abstract] [Full Text] [Related]
15. Misunderstanding or error? The UGDP report after four years.
Marigo S; Adezati L; Burnetti P; Pozza G; Robba L; Urbinati G
Acta Diabetol Lat; 1974; 11(5):357-422. PubMed ID: 4156992
[No Abstract] [Full Text] [Related]
16. FDA upholds findings of UGDP study.
JAMA; 1979 Jan; 241(1):17-8. PubMed ID: 758481
[No Abstract] [Full Text] [Related]
17. Letter: The UGDP study.
Hubbard WM
JAMA; 1975 Mar; 231(11):1133-4. PubMed ID: 1172807
[No Abstract] [Full Text] [Related]
18. Letter: The UGDP scandal and cover-up.
Moss JM
JAMA; 1975 May; 232(8):806-8. PubMed ID: 1173182
[No Abstract] [Full Text] [Related]
19. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
Pirart J
Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
[No Abstract] [Full Text] [Related]
20. Oral hypoglycaemic agents--dangers and contraindications.
Ennis G
Med J Aust; 1976 Oct; 2(16):605, 608-9. PubMed ID: 1004309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
